PET-MR can predict survival and response in advanced hepatocellular carcinoma patients treated with sorafenib

被引：0
|
作者：
Hwang, Jae-Pil [1 ]
Lim, Ilhan [1 ]
Han, Chul Ju [2 ]
Park, Su Cheol [2 ]
Kim, Young Han [3 ]
Park, Joon Yeun [1 ]
Kim, Kyeong Min [1 ]
Kim, Byung Il [1 ]
Choi, Chang Woon [1 ]
Lim, Sang Moo [1 ]
机构：
[1] Korea Canc Ctr Hosp, Nucl Med, Seoul, South Korea
[2] Korea Canc Ctr Hosp, Internal Med, Seoul, South Korea
[3] Korea Canc Ctr Hosp, Radiol, Seoul, South Korea
来源：
JOURNAL OF NUCLEAR MEDICINE | 2012年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
61
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Survival and adverse events of elderly patients treated with sorafenib for hepatocellular carcinoma
    Soria, Anna
    Calvo, Mariona
    Casas, Meritxell
    Vidales, Zara
    Munoz-Martinez, Sergio
    Sapena, Victor
    Puigvehi, Marc
    Canillas, Lidia
    Guardeno, Raquel
    Gallego, Adolfo
    Minguez, Beatriz
    Horta, Diana
    Clos, Ariadna
    Montoliu, Silvia
    Roget, Merce
    Reig, Maria
    Vergara, Mercedes
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [42] The effect of locoregional therapies in patients with advanced hepatocellular carcinoma treated with sorafenib
    Sarpel, Umut
    Spivack, John H.
    Berger, Yaniv
    Heskel, Marina
    Aycart, Samantha N.
    Sweeney, Robert
    Edwards, Martin P.
    Labow, Daniel M.
    Kim, Edward
    HPB, 2016, 18 (05) : 411 - 418
  • [43] Targeted genome profiling in patients with advanced hepatocellular carcinoma treated with sorafenib
    Kang, Wonseok
    Kim, Kyung
    Lee, Joon Hyeok
    Lim, Ho Yeong
    Park, Woong-Yang
    Lee, Jeeyun
    Paik, Yong Han
    CANCER RESEARCH, 2017, 77
  • [44] The impact of patient and tumour baseline characteristics on the overall survival of patients with advanced hepatocellular carcinoma treated with sorafenib
    Woerns, Marcus A.
    Koch, Sandra
    Niederle, Ina M.
    Marquardt, Jens U.
    Nguyen-Tat, Marc
    Gamstaetter, Thomas
    Schuchmann, Marcus
    Schulze-Bergkamen, Henning
    Galle, Peter R.
    Weinmann, Arndt
    DIGESTIVE AND LIVER DISEASE, 2013, 45 (05) : 408 - 413
  • [45] Survival of patients with advanced hepatocellular carcinoma: Sorafenib versus other treatments
    Kim, Hwi Young
    Park, Joong-Won
    Nam, Byung-Ho
    Kim, Hyun Keun
    Choi, Joon-Il
    Kim, Tae Hyun
    Kim, Hyun Beom
    Kim, Chang-Min
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 (11) : 1612 - 1618
  • [46] Predictors of survival in patients with established cirrhosis and hepatocellular carcinoma treated with sorafenib
    Andrea L Inghilesi
    Donatella Gallori
    Lorenzo Antonuzzo
    Paolo Forte
    Daniela Tomcikova
    Umberto Arena
    Stefano Colagrande
    Silvia Pradella
    Bernardo Fani
    Elena Gianni
    Luca Boni
    Giacomo Laffi
    Francesco Di Costanzo
    Fabio Marra
    World Journal of Gastroenterology, 2014, 20 (03) : 786 - 794
  • [47] Prognostic impact of pERK in advanced hepatocellular carcinoma patients treated with sorafenib
    Chen, D.
    Zhao, P.
    Li, S. -Q.
    Xiao, W. -K.
    Yin, X. -Y.
    Peng, B. -G.
    Liang, L. -J.
    EJSO, 2013, 39 (09): : 974 - 980
  • [48] Stem Cell Markers Predict the Response to Sorafenib in Patients with Hepatocellular Carcinoma
    Kim, Bo Hyun
    Park, Joong-Won
    Kim, Jin Sook
    Lee, Sook-Kyung
    Hong, Eun Kyung
    GUT AND LIVER, 2019, 13 (03) : 342 - 348
  • [49] Baseline Interleukin-6 and -8 predict response and survival in patients with advanced hepatocellular carcinoma treated with sorafenib monotherapy: an exploratory post hoc analysis of the SORAMIC trial
    Osman Öcal
    Kerstin Schütte
    Juozas Kupčinskas
    Egidijus Morkunas
    Gabija Jurkeviciute
    Enrico N. de Toni
    Najib Ben Khaled
    Thomas Berg
    Peter Malfertheiner
    Heinz Josef Klümpen
    Christian Sengel
    Bristi Basu
    Juan W. Valle
    Julia Benckert
    Antonio Gasbarrini
    Daniel Palmer
    Ricarda Seidensticker
    Moritz Wildgruber
    Bruno Sangro
    Maciej Pech
    Jens Ricke
    Max Seidensticker
    Journal of Cancer Research and Clinical Oncology, 2022, 148 : 475 - 485
  • [50] Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients
    Chung, Min-Woo
    Kim, Moon-Ju
    Won, Eun Jeong
    Lee, Yu Jeong
    Yun, Yong-Woon
    Cho, Sung Bum
    Joo, Young-Eun
    Hwang, Jun-Eul
    Bae, Woo Kyun
    Chung, Ik-Joo
    Shin, Myung Geun
    Shin, Jong Hee
    WORLD JOURNAL OF GASTROENTEROLOGY, 2021, 27 (42) : 7340 - 7349
12345